企業プロフィール
PROCEPT BioRobotics 株価・ニュース・カタリスト
- ティッカー:
- PRCT
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
21.09 USD (-2.59%)
終値
最終更新: 2026年8月17日
1.52B USD
時価総額
株価変動の要因
Following the latest company update, “PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026”, PRCT closed down 2.59% at $21.09 on Aug 17, 2026. The move occurred in the trading session associated with this conference / presentation update.
企業概要
Urology Robotics
PROCEPT BioRobotics develops robotic systems for the surgical treatment of benign prostatic hyperplasia. Its technology is designed to standardize tissue removal while preserving outcomes across different prostate sizes and anatomies.
Aquablation Therapy
Aquablation uses a robotically controlled, heat-free waterjet to remove obstructive prostate tissue. The procedure is planned from imaging and is intended to reduce dependence on surgeon technique compared with manually executed resection.
HYDROS Platform
The HYDROS Robotic System is the company’s current AI-enabled platform for Aquablation. Its FirstAssist AI software supports personalized image-guided planning, while recurring handpiece sales create a procedure-linked revenue stream alongside capital-system placements.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。